Institutional shares held 69.3 Million
127K calls
85.5K puts
Total value of holdings $513M
$940K calls
$632K puts
Market Cap $544M
73,461,104 Shares Out.
Institutional ownership 94.35%
# of Institutions 188


Latest Institutional Activity in DAWN

Top Purchases

Q2 2025
Deerfield Management Company, L.P. (Series C) Shares Held: 3.72M ($27.6M)
Q2 2025
Qube Research & Technologies LTD Shares Held: 944K ($6.99M)
Q2 2025
Renaissance Technologies LLC Shares Held: 1M ($7.4M)
Q2 2025
Morgan Stanley Shares Held: 1.35M ($10M)
Q2 2025
J. Goldman & CO LP Shares Held: 557K ($4.13M)

Top Sells

Q2 2025
Braidwell LP Shares Held: 2.18M ($16.1M)
Q2 2025
Alyeska Investment Group, L.P. Shares Held: 3.01M ($22.3M)
Q2 2025
Citadel Advisors LLC Shares Held: 704K ($5.21M)
Q2 2025
Parkman Healthcare Partners LLC Shares Held: 500K ($3.7M)
Q2 2025
Aqr Capital Management LLC Shares Held: 280K ($2.07M)

About DAWN

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.


Insider Transactions at DAWN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
652K Shares
From 6 Insiders
Exercise of conversion of derivative security 250K shares
Bona fide gift 402K shares
Sell / Disposition
796K Shares
From 6 Insiders
Open market or private sale 195K shares
Bona fide gift 601K shares

Track Institutional and Insider Activities on DAWN

Follow Day One Biopharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

News

Receive news related to Day One Biopharmaceuticals, Inc.

Track Activities on DAWN